Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women
- PMID: 21091128
- PMCID: PMC3132065
- DOI: 10.1089/aid.2010.0169
Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women
Abstract
To address an existing controversy concerning the presence of HIV-1-specific antibodies of the IgA isotype in the female genital tract secretions of highly-exposed but persistently seronegative (HEPSN) women, 41 samples of plasma and cervicovaginal lavage (CVL) fluid were distributed to six laboratories for their blinded evaluation using ELISA with 10 different HIV-1 antigens, chemiluminescence-enhanced Western blots (ECL-WB), and virus neutralization. HIV-specific IgG or IgA antibodies in plasma samples from HEPSN women were absent or detectable only at low levels. In CVL, 11/41 samples displayed low levels of reactivity in ELISA against certain antigens. However, only one sample was positive in two of five laboratories. All but one CVL sample yielded negative results when analyzed by ECL-WB. Viral neutralizing activity was either absent or inconsistently detected in plasma and CVL. Plasma and CVL samples from 26 HIV-1-infected women were used as positive controls. Irrespective of the assays and antigens used, the results generated in all laboratories displayed remarkable concordance in the detection of HIV-1-specific antibodies of the IgG isotype. In contrast, IgA antibodies to HIV-1 antigens were not detected with consistency, and where present, IgA antibodies were at markedly lower levels than IgG. Although HIV-neutralizing activity was detected in plasma of all HIV-1-infected women, only a few of their CVL samples displayed such activity. In conclusion, frequent HIV-1 sexual exposure does not stimulate uniformly detectable mucosal or systemic HIV-1-specific responses, as convincingly documented in the present blindly performed study using a broad variety of immunological assays. Although HIV-1-infection leads to vigorous IgG responses in plasma and CVL, it does not stimulate sustained IgA responses in either fluid.
Figures

Similar articles
-
Humoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women.Am J Reprod Immunol. 2014 Jun;71(6):600-7. doi: 10.1111/aji.12203. Epub 2014 Feb 5. Am J Reprod Immunol. 2014. PMID: 24494997 Free PMC article. Review.
-
Quantitation of HIV-1-specific IgG, IgA, and IgM antibodies in human genital tract secretions.J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jul 1;15(3):185-91. doi: 10.1097/00042560-199707010-00001. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9257652
-
Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.New Microbiol. 2000 Jan;23(1):85-92. New Microbiol. 2000. PMID: 10946410
-
Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women.AIDS. 2016 Apr 24;30(7):1005-14. doi: 10.1097/QAD.0000000000001038. AIDS. 2016. PMID: 26836790 Free PMC article.
-
Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection.J Reprod Immunol. 2009 Dec;83(1-2):196-200. doi: 10.1016/j.jri.2009.07.005. Epub 2009 Oct 23. J Reprod Immunol. 2009. PMID: 19853927 Free PMC article. Review.
Cited by
-
Evaluation of Mucosal Humoral and Cellular Immune Responses to HIV in External Secretions and Mucosal Tissues.Curr Immunol Rev. 2019;15(1):41-48. doi: 10.2174/1573395514666180621152303. Curr Immunol Rev. 2019. PMID: 33312087 Free PMC article.
-
Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity.J Virol. 2019 Aug 13;93(17):e00772-19. doi: 10.1128/JVI.00772-19. Print 2019 Sep 1. J Virol. 2019. PMID: 31217246 Free PMC article.
-
Humoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women.Am J Reprod Immunol. 2014 Jun;71(6):600-7. doi: 10.1111/aji.12203. Epub 2014 Feb 5. Am J Reprod Immunol. 2014. PMID: 24494997 Free PMC article. Review.
-
Phase I randomised clinical trial of an HIV-1(CN54), clade C, trimeric envelope vaccine candidate delivered vaginally.PLoS One. 2011;6(9):e25165. doi: 10.1371/journal.pone.0025165. Epub 2011 Sep 30. PLoS One. 2011. PMID: 21984924 Free PMC article. Clinical Trial.
-
HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis.J Virol. 2016 Oct 14;90(21):9855-9861. doi: 10.1128/JVI.01482-16. Print 2016 Nov 1. J Virol. 2016. PMID: 27558421 Free PMC article. Clinical Trial.
References
-
- Artenstein AW. VanCott TC. Sitz KV, et al. Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: A comparison by site and correlation with clinical information. J Infect Dis. 1997;175:265–271. - PubMed
-
- Moog C. Immune responses that correlate with HIV-1 protection? AIDS. 2008;22:1461–1462. - PubMed
-
- Nguyen M. Pean P. Lopalco L, et al. HIV-specific antibodies but not T-cell responses are associated with protection in seronegative partners of HIV-1-infected individuals in Cambodia. J Acquir Immune Defic Syndr. 2006;42:412–419. - PubMed
-
- Novak RM. Donoval BA. Graham PJ, et al. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Clin Vaccine Immunol. 2007;14:1102–1107. - PMC - PubMed
-
- Baba TW. Liska V. Hofmann–Lehmann R, et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med. 2000;6:200–206. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous